Greenbrook TMS Inc. (OTCQB: GBNHF) ("Greenbrook" or the "Company") today announced its third quarter 2024 ("Q3 2024") operational ...

Go to breakfast.fool.com to sign up to wake up daily to the latest market news, company insights, and a bit of Foolish fun -- ...

Despite prices reaching an all-time low, there was an uptick in marijuana sales from September to October, with all-time ...

Reedsport joined a handful of other Oregon cities in instituting a ban on psilocybin production and sales facilities in the ...

The psychedelic drugs market was valued at $0.7 billion in 2022 and is projected to reach $2.6 billion by 2032, growing at a CAGR of 13.4% from 2023 to 2032.

Arapahoe County commissioners have unanimously approved a comprehensive set of regulations governing psilocybin businesses as Colorado prepares to begin licensing these operations in January 2025. The ...

A “suspicious package” mailed to a California business led authorities to a property with more than 2,800 bags of psilocybin ...

Tryptamine Therapeutics (Tryp) has announced the completion of subject dosing in a Phase Ib clinical trial of TRP-8803, for ...

When Jonathan Dalton first heard about psychedelic therapy, it sounded like a “bunch of hippie drugs” for “hippie veterans.” ...

A clinical trial found psilocybin treatment for anorexia nervosa led to profound psychological shifts and reduced eating ...